EE9900092A - PTX-tundlikud G-valgud, nende valmistamine ja kasutamine - Google Patents

PTX-tundlikud G-valgud, nende valmistamine ja kasutamine

Info

Publication number
EE9900092A
EE9900092A EEP199900092A EE9900092A EE9900092A EE 9900092 A EE9900092 A EE 9900092A EE P199900092 A EEP199900092 A EE P199900092A EE 9900092 A EE9900092 A EE 9900092A EE 9900092 A EE9900092 A EE 9900092A
Authority
EE
Estonia
Prior art keywords
ptx
proteins
sensitive
preparation
Prior art date
Application number
EEP199900092A
Other languages
English (en)
Estonian (et)
Inventor
Siffert Winfried
Original Assignee
Siffert Winfried
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siffert Winfried filed Critical Siffert Winfried
Publication of EE9900092A publication Critical patent/EE9900092A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
EEP199900092A 1996-09-13 1997-08-29 PTX-tundlikud G-valgud, nende valmistamine ja kasutamine EE9900092A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19637518A DE19637518A1 (de) 1996-09-13 1996-09-13 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung
PCT/EP1997/004709 WO1998011212A1 (de) 1996-09-13 1997-08-29 Ptx-sensitive g-proteine, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
EE9900092A true EE9900092A (et) 1999-10-15

Family

ID=7805651

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900092A EE9900092A (et) 1996-09-13 1997-08-29 PTX-tundlikud G-valgud, nende valmistamine ja kasutamine

Country Status (22)

Country Link
US (1) US6251853B1 (cs)
EP (1) EP0931145A1 (cs)
JP (1) JP2001501811A (cs)
KR (1) KR20000036058A (cs)
CN (1) CN1230222A (cs)
AU (1) AU4619297A (cs)
BG (1) BG103238A (cs)
BR (1) BR9711475A (cs)
CA (1) CA2265467A1 (cs)
CZ (1) CZ73499A3 (cs)
DE (1) DE19637518A1 (cs)
EA (1) EA199900253A1 (cs)
EE (1) EE9900092A (cs)
HU (1) HUP9904110A3 (cs)
IL (1) IL128746A0 (cs)
IS (1) IS4987A (cs)
NO (1) NO991227D0 (cs)
PL (1) PL332417A1 (cs)
SK (1) SK34099A3 (cs)
TR (1) TR199900500T2 (cs)
WO (1) WO1998011212A1 (cs)
ZA (1) ZA978220B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen
WO1999058669A1 (en) * 1998-05-11 1999-11-18 Axys Pharmaceuticals, Inc. Rhoh genes and their uses
AU6079999A (en) * 1998-09-10 2000-04-03 Winfried Siffert Gene modification in the gene for the die gbeta3-sub-unit of human g-protein
FR2803525B1 (fr) * 2000-01-06 2002-05-03 Sod Conseils Rech Applic Inhibiteur de la transduction des signaux des proteines g heterotrimeriques associe a un agent anti-hypertenseur dans le traitement de l'hypertension arterielle
WO2001057246A1 (de) * 2000-02-03 2001-08-09 Winfried Siffert VERWENDUNG EINER GENVERÄNDERUNG IM GEN FÜR DIE β3-UNTEREINHEIT DES HUMANEN G-PROTEINS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587561A (en) 1995-07-28 1996-12-24 Budayr; Mahdi Stethoscope shield
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen

Also Published As

Publication number Publication date
IS4987A (is) 1999-02-26
PL332417A1 (en) 1999-09-13
DE19637518A1 (de) 1998-04-09
HUP9904110A3 (en) 2001-09-28
US6251853B1 (en) 2001-06-26
BG103238A (bg) 2000-06-30
NO991227L (no) 1999-03-12
AU4619297A (en) 1998-04-02
EP0931145A1 (de) 1999-07-28
CZ73499A3 (cs) 1999-07-14
CA2265467A1 (en) 1998-03-19
HUP9904110A2 (en) 2000-07-28
WO1998011212A1 (de) 1998-03-19
CN1230222A (zh) 1999-09-29
IL128746A0 (en) 2000-01-31
BR9711475A (pt) 1999-08-24
NO991227D0 (no) 1999-03-12
EA199900253A1 (ru) 1999-10-28
JP2001501811A (ja) 2001-02-13
ZA978220B (en) 1999-03-12
SK34099A3 (en) 2000-05-16
KR20000036058A (ko) 2000-06-26
TR199900500T2 (xx) 1999-06-21

Similar Documents

Publication Publication Date Title
FI964311L (fi) Bifunktionaalinen proteiini, valmistus ja käyttö
EE05538B1 (et) Interleukiin-18 seostuvad valgud, nende valmistamine ja kasutamine
BR9708400A (pt) Composição sua preparação e uso
NL300295I2 (nl) 3,3-diarylpropylaminen, de toepassing en bereidinghiervan
EE9900147A (et) Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
ID16224A (id) Bikunin manusia
ATE259241T1 (de) Wässrige peptidzubereitung
FI955235A7 (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
FI951468L (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
FI990134L (fi) Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina
DE59707298D1 (de) Desodorierende zubereitungen
FI970997A7 (fi) Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö
FI963334A7 (fi) Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
FI951726A7 (fi) Boronihappopeptidijohdannaisia, niiden valmistus ja käyttö synteesivälituotteina
EE9800451A (et) Uued imidasotriasolopürimidiinid, nende valmistamismeetod ja kasutamine ravimainetena
EP1012262A4 (en) Human frezzled-like protein
EE9900092A (et) PTX-tundlikud G-valgud, nende valmistamine ja kasutamine
TR199701666A3 (tr) Sismanliga karsi proteinler
FI972965A7 (fi) Uusia peptidejä, niiden valmistus ja käyttö
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
FI950516L (fi) Interferoni-alfa/beta-sitojaproteiini, sen valmistus ja käyttö
FI971317A7 (fi) Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö
FI971872A0 (fi) Proteiinikoostumus ja sen valmistus ja käyttö sekä sitä sisältävät valmisteet ja näiden valmistus
FI964446L (fi) Uusia tetrapeptidejä, niiden valmistus ja käyttö
FI965172L (fi) Uusia amido-kinoksaliinidioneja, niiden valmistus ja käyttö